| 1 |
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al. · European Heart Journal
Open access134 authors |
20 May 2016 |
11,598 |
| 2 |
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al. · European Heart Journal
Open access211 authors |
25 Aug 2018 |
10,602 |
| 3 |
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
John J.V. McMurray et al. · New England Journal of Medicine
Open access |
19 Sep 2019 |
7,135 |
| 4 |
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Piotr P. Ponikowski et al. · European Journal of Heart Failure
Open access |
20 May 2016 |
5,934 |
| 5 |
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al. · New England Journal of Medicine
Open access |
28 Aug 2020 |
5,214 |
| 6 |
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Victor Aboyans et al. · European Heart Journal
Open access119 authors |
26 Aug 2017 |
3,338 |
| 7 |
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
Ami D. Sperber et al. · Gastroenterology
Open access |
12 Apr 2020 |
2,280 |
| 8 |
Photodynamic therapy – mechanisms, photosensitizers and combinations
Stanisław Kwiatkowski, Bartosz Knap, Dawid Przystupski et al. · Biomedicine & Pharmacotherapy
|
17 Jul 2018 |
2,182 |
| 9 |
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Stefan D. Anker, Josep Comín Colet, Gerasimos S Filippatos et al. · New England Journal of Medicine
Open access |
17 Nov 2009 |
2,090 |
| 10 |
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
Salim Yusuf et al. · The Lancet
Open access |
3 Sep 2019 |
2,054 |
| 11 |
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
Tomi Akinyemiju et al. · JAMA Oncology
Open access |
5 Oct 2017 |
2,044 |
| 12 |
Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study
Darryl P. Leong et al. · The Lancet
Open access |
13 May 2015 |
1,905 |
| 13 |
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Mathias Pieske et al. · European Heart Journal
Open access |
27 Aug 2019 |
1,880 |
| 14 |
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
Deepak L. Bhatt, Michael J. Szarek, Philippe Gabríel Steg et al. · New England Journal of Medicine
Open access |
16 Nov 2020 |
1,872 |
| 15 |
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balázs Győrffy, Paweł Surowiak, Jan Budczies et al. · PLoS ONE
Open access |
18 Dec 2013 |
1,863 |
| 16 |
Stem cells: past, present, and future
Wojciech Zakrzewski, Maciej Dobrzyński, Maria Krystyna Szymonowicz et al. · Stem Cell Research & Therapy
Open access |
26 Feb 2019 |
1,853 |
| 17 |
Heart Failure: Preventing Disease and Death Worldwide
Piotr P. Ponikowski, Stefan D. Anker, Khalid F. AlHabib et al. · ESC Heart Failure
Open access |
Sep 2014 |
1,717 |
| 18 |
Population genomics of Bronze Age Eurasia
Morten E. Allentoft et al. · Nature
Open access |
9 Jun 2015 |
1,663 |
| 19 |
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
Willemijn J. Jansen et al. · JAMA
Open access129 authors |
19 May 2015 |
1,662 |
| 20 |
Mental disorders among college students in the World Health Organization World Mental Health Surveys
Randy Patrick Auerbach et al. · Psychological Medicine
Open access |
3 Aug 2016 |
1,639 |
| 21 |
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016
Christina Fitzmaurice et al. · JAMA Oncology
Open access153 authors |
2 Jun 2018 |
1,550 |
| 22 |
The State of US Health, 1990-2016
The US Burden of Disease Collaborators et al. · JAMA
Open access116 authors |
10 Apr 2018 |
1,472 |
| 23 |
The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study
Scott Alexander Lear et al. · The Lancet
Open access |
22 Sep 2017 |
1,390 |
| 24 |
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Paul W. Armstrong, Burkert Mathias Pieske, Kevin Joseph Anstrom et al. · New England Journal of Medicine
Open access |
28 Mar 2020 |
1,350 |
| 25 |
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
Piotr P. Ponikowski, Dirk J. van Veldhuisen, Josep Comín‐Colet et al. · European Heart Journal
Open access |
31 Aug 2014 |
1,245 |
| 26 |
Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
Andreas Wollenberg, S. Barbarot, Thomas R.M. Bieber et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
20 Apr 2018 |
1,191 |
| 27 |
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
Hervé Dombret et al. · Blood
Open access |
18 May 2015 |
1,168 |
| 28 |
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
Harry L.A. Janssen, Monika van Zonneveld, Hakan Şentürk et al. · The Lancet
|
2005 |
1,165 |
| 29 |
Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study
Mahshid Dehghan et al. · The Lancet
Open access362 authors |
29 Aug 2017 |
1,126 |
| 30 |
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
Claudio Ronco et al. · European Heart Journal
Open access |
25 Dec 2009 |
1,099 |
| 31 |
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
Alexandre Mebazaa, Beth A. Davison, Ovidiu Chioncel et al. · The Lancet
Open access |
7 Nov 2022 |
1,098 |
| 32 |
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Christos C. Zouboulis, Nemesha Desai, Lennart Emtestam et al. · Journal of the European Academy of Dermatology and Venereology
|
30 Jan 2015 |
1,095 |
| 33 |
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Kumar Ray et al. · Nature Medicine
|
14 Oct 2007 |
1,071 |
| 34 |
The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
Beata Kowalska−Krochmal, Ruth K. Dudek-Wicher · Pathogens
Open access |
4 Feb 2021 |
1,063 |
| 35 |
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology
Antonella Maria Muraro et al. · Allergy
Open access |
9 Jun 2014 |
1,059 |
| 36 |
Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries
Salim Yusuf et al. · New England Journal of Medicine
Open access |
27 Aug 2014 |
1,012 |
| 37 |
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
Tracy Ann Williams et al. · The Lancet Diabetes & Endocrinology
Open access |
31 May 2017 |
978 |
| 38 |
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
Florence J. Dalgard, Uwe Gieler, Lucía Tomás Aragonés et al. · Journal of Investigative Dermatology
Open access |
18 Dec 2014 |
978 |
| 39 |
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Adriaan A. Voors et al. · Nature Medicine
Open access |
28 Feb 2022 |
934 |
| 40 |
EAACI Molecular Allergology User's Guide
Paolo Maria Matricardi et al. · Pediatric Allergy and Immunology
Open access |
May 2016 |
926 |
| 41 |
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
John R. Teerlink et al. · The Lancet
|
6 Nov 2012 |
919 |
| 42 |
IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy
Marek Jutel, Mübeccel Akdiş, Ferah Budak et al. · European Journal of Immunology
|
7 Apr 2003 |
917 |
| 43 |
Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events
Martin James O'Donnell et al. · New England Journal of Medicine
Open access |
13 Aug 2014 |
903 |
| 44 |
Definition of treatment goals for moderate to severe psoriasis: a European consensus
Ulrich Mrowietz et al. · Archives of Dermatological Research
Open access |
20 Sep 2010 |
898 |
| 45 |
Association of Urinary Sodium and Potassium Excretion with Blood Pressure
Andrew Mente et al. · New England Journal of Medicine
Open access |
13 Aug 2014 |
865 |
| 46 |
The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys
on behalf of the WHO World Mental Health Survey Collaborators et al. · ADHD Attention Deficit and Hyperactivity Disorders
Open access |
19 Nov 2016 |
836 |
| 47 |
Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe
Walid Habre et al. · The Lancet Respiratory Medicine
Open access1,004 authors |
28 Mar 2017 |
826 |
| 48 |
Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Karol Kowalski, Agata Mulak · Journal of Neurogastroenterology and Motility
Open access |
10 Jan 2019 |
824 |
| 49 |
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis
Graham Roberts et al. · Allergy
Open access |
23 Sep 2017 |
806 |
| 50 |
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
Piotr P. Ponikowski et al. · The Lancet
Open access210 authors |
13 Nov 2020 |
797 |